NASDAQ: SNSE
Sensei Biotherapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for SNSE

Based on 4 analysts offering 12 month price targets for Sensei Biotherapeutics Inc

Min Forecast
$30.00+259.07%
Avg Forecast
$72.50+767.74%
Max Forecast
$100.00+1,096.89%

Should I buy or sell SNSE stock?

Based on 4 analysts offering ratings for Sensei Biotherapeutics Inc.

Buy
Strong Buy
0 analysts 0%
Buy
4 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their SNSE stock forecasts and price targets.

SNSE stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-08-05
lockedlocked$00.00+00.00%2025-06-02
lockedlocked$00.00+00.00%2025-03-28
lockedlocked$00.00+00.00%2025-03-28

1 of 1

Forecast return on equity

Is SNSE forecast to generate an efficient return?

Company
N/A
Industry
121.84%
Market
-49.65%

Forecast return on assets

Is SNSE forecast to generate an efficient return on assets?

Company
N/A
Industry
45.6%

SNSE earnings per share forecast

What is SNSE's earnings per share in the next 3 years based on estimates from 2 analysts?

Avg 1 year Forecast
-$18.79
Avg 2 year Forecast
-$14.93
Avg 3 year Forecast
-$12.43

SNSE vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
SNSE$8.36$72.50+767.74%Buy
LIXT$3.92N/AN/A
ERNA$1.38N/AN/A
PCSA$0.21$2.00+843.40%Buy
MTNB$2.04N/AN/A

Sensei Biotherapeutics Stock Forecast FAQ

Is Sensei Biotherapeutics Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: SNSE) stock is to Buy SNSE stock.

Out of 4 analysts, 0 (0%) are recommending SNSE as a Strong Buy, 4 (100%) are recommending SNSE as a Buy, 0 (0%) are recommending SNSE as a Hold, 0 (0%) are recommending SNSE as a Sell, and 0 (0%) are recommending SNSE as a Strong Sell.

If you're new to stock investing, here's how to buy Sensei Biotherapeutics stock.

What is SNSE's earnings growth forecast for 2025-2027?

(NASDAQ: SNSE) Sensei Biotherapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 5.19%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 14.9%.

Sensei Biotherapeutics's earnings in 2025 is -$26,823,000.On average, 2 Wall Street analysts forecast SNSE's earnings for 2025 to be -$23,693,333, with the lowest SNSE earnings forecast at -$24,469,026, and the highest SNSE earnings forecast at -$22,917,639. On average, 2 Wall Street analysts forecast SNSE's earnings for 2026 to be -$18,824,753, with the lowest SNSE earnings forecast at -$18,982,415, and the highest SNSE earnings forecast at -$18,667,092.

In 2027, SNSE is forecast to generate -$15,677,835 in earnings, with the lowest earnings forecast at -$15,677,835 and the highest earnings forecast at -$15,677,835.

What is SNSE's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: SNSE) forecast ROE is N/A, which is considered weak.

What is SNSE's Price Target?

According to 4 Wall Street analysts that have issued a 1 year SNSE price target, the average SNSE price target is $72.50, with the highest SNSE stock price forecast at $100.00 and the lowest SNSE stock price forecast at $30.00.

On average, Wall Street analysts predict that Sensei Biotherapeutics's share price could reach $72.50 by Aug 5, 2026. The average Sensei Biotherapeutics stock price prediction forecasts a potential upside of 767.74% from the current SNSE share price of $8.36.

What is SNSE's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: SNSE) Sensei Biotherapeutics's current Earnings Per Share (EPS) is -$21.31. On average, analysts forecast that SNSE's EPS will be -$18.79 for 2025, with the lowest EPS forecast at -$19.40, and the highest EPS forecast at -$18.17. On average, analysts forecast that SNSE's EPS will be -$14.93 for 2026, with the lowest EPS forecast at -$15.05, and the highest EPS forecast at -$14.80. In 2027, SNSE's EPS is forecast to hit -$12.43 (min: -$12.43, max: -$12.43).

What is SNSE's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: SNSE) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 45.6%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.